Parenteral Drugs Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2022	Dec-2021	Sep-2021	Jun-2021	Mar-2021
Gross Sales	1.77	1.44	2.35	2.93	2.57
Excise Duty	--	--	--	--	--
Net Sales	1.77	1.44	2.35	2.93	2.57
Other Operating Income	--	--	--	--	--
Other Income	52.25	0.01	0.01	0.01	0.03
Total Income	54.02	1.45	2.36	2.94	2.60
Total Expenditure	7.66	4.67	5.62	5.57	(0.82)
PBIDT	46.37	(3.21)	(3.26)	(2.62)	3.42
Interest	--	36.68	35.47	34.10	32.46
PBDT	46.36	(39.90)	(38.72)	(36.72)	(29.04)
Depreciation	27.15	4.33	4.33	4.33	4.32
Minority Interest Before NP	--	--	--	--	--
Tax	--	--	--	--	--
Deferred Tax	(4.60)	(9.70)	(9.44)	(9.02)	(8.51)
Reported Profit After Tax	23.81	(34.52)	(33.61)	(32.04)	(24.85)
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	23.81	(34.52)	(33.61)	(32.04)	(24.85)
Extra-ordinary Items	52.21	--	--	--	--
Adjusted Profit After Extra-ordinary item	(28.40)	(34.52)	(33.61)	(32.04)	(24.85)
EPS (Unit Curr.)	7.99	(11.58)	(11.28)	(10.74)	(8.33)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	29.81	29.82	29.82	29.82	29.82
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	2619.77	(222.92)	(138.72)	(89.42)	133.07
PBDTM(%)	2619.21	(2,770.83)	(1,647.66)	(1,253.24)	(1,129.96)
PATM(%)	1345.20	(2,397.22)	(1,430.21)	(1,093.52)	(966.93)

QuickLinks for Parenteral Drugs (India) Ltd.